SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review

DOI: 10.4239/wjd.v10.i2.114

Keywords: Alanine aminotransferase, Hepatic fat, Hepatic fibrosis, Non-alcoholic fatty liver disease, Sodium-glucose cotransporter-2 inhibitor, Type 2 diabetes mellitus

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text